A case of groans, moans and stones with malignant undertones: Endometrioid carcinoma-associated hypercalcemia

Stewart AF: Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 352:373–379. 2005. View Article : Google Scholar : PubMed/NCBI

Hiller N, Sonnenblick M and Hershko C: Paraneoplastic hypercalcemia in endometrial carcinoma. Oncology. 46:45–48. 1989. View Article : Google Scholar : PubMed/NCBI

Buller R, Taylor K, Burg AC, Berman ML and DiSaia PJ: Paraneoplastic hypercalcemia associated with adenosquamous carcinoma of the endometrium. Gynecol Oncol. 40:95–98. 1991. View Article : Google Scholar : PubMed/NCBI

Sachmechi I, Kalra J, Molho L and Chawla K: Paraneoplastic hypercalcemia associated with uterine papillary serous carcinoma. Gynecol Oncol. 58:378–82. 1995. View Article : Google Scholar : PubMed/NCBI

Kinugasa Y, Morishige K, Kamiura S, Tsukamoto Y and Saji F: Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma. Jpn J Clin Oncol. 36:113–115. 2006. View Article : Google Scholar : PubMed/NCBI

Ashour AA, Verschraegen CF, Kudelka AP and Kavanagh JJ: Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol. 15:1272–1282. 1997.PubMed/NCBI

Savvari P, Peitsidis P, Alevizaki M, Dimopoulos MA, Antsaklis A and Papadimitriou CA: Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie. 32:517–23. 2009. View Article : Google Scholar

Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis WJ, et al: Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med. 319:556–563. 1988.PubMed/NCBI

Hoshi S, Morimoto T, Saito H, Ichizuka K, Matsuoka R, Yanaihara A, et al: PTHrP and PTH/PTHrP receptor expressions in human endometrium. Endocr J. 48:219–225. 2001. View Article : Google Scholar : PubMed/NCBI

Mok LL, Nickols GA, Thompson JC and Cooper CW: Parathyroid hormone as a smooth muscle relaxant. Endocr Rev. 10:420–436. 1989. View Article : Google Scholar : PubMed/NCBI

Williams ED, Leaver DD, Danks JA, Moseley JM and Martin TJ: Effect of parathyroid hormone-related protein (PTHrP) on the contractility of the myometrium and localization of PTHrP in the uterus of pregnant rats. J Reprod Fertil. 102:209–214. 1994. View Article : Google Scholar : PubMed/NCBI

Heffner LJ, Kumari M and Benoit LA: Secretion of the vasoactive peptides, endothelin, and parathyroid hormone-related peptide, by decidual explants from pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig. 6:273–277. 1999. View Article : Google Scholar

Schilling T, Pecherstorfer M, Blind E, Leidig G, Ziegler R and Raue F: Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab. 76:801–803. 1993.PubMed/NCBI

Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocana A, Wisniewski SR and Stewart AF: Parathyroid hormone-related protein-(1–36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab. 86:1525–1531. 2001.

Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, et al: Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients. Int J Gynecol Cancer. 19:178–185. 2009. View Article : Google Scholar : PubMed/NCBI

Richey DS and Welch BJ: Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer. South Med J. 101:1266–1268. 2008. View Article : Google Scholar : PubMed/NCBI